Document:

Exhibit 10.1

 

SECOND AMENDMENT TO LICENSE AGREEMENT

 

Relating to

Encapsulated Cells Producing Viral Particles

and

Encapsulated Cells Expressing Biomolecules

 

LICENSORS

 

 

Bavarian Nordic A/S, reg. no. 16271187

 

a company incorporated in Denmark, whose registered
office is at Hejreskovvej 10A,

DK-3490 Kvistgard, Dennmark

 

and

 

Helmholtz Zentrum Miinchen/GSF — Forschungszentrum
fur Umwelt u.

Gesundheit GmbH,

 

Ingolstadter Landstr. 1, D-85764 Neuherberg,
Deutschland

 

and

 

LICENSEE

 

Bio Blue Bird AG,

 

Pflugstr. 7, FL-9490 Vaduz, Liechtenstein

 

 

    	 	 	 

     

    

 

This Second Amendment to Licensee Agreement ("Second Amendment") is made effective as of
the 1st day of October 2016 ("Effective Date of the Second Amendment") between:

 

		(1)	BAVARIAN NORDIC A/S, reg. no. 16271187, a company incorporated in Denmark, whose registered office is at Hejreskovvej
10A, DK-3490 Kvistgard, Denmark ("BAVARIAN NORDIC") and
	 	 	 
		(2)	Helmholtz Zentrum Munchen/GSF-Forschungszentrum fur Umwelt u. Gesundheit GmbH, Ingolstadter Landstr. 1, D-85764 Neuherberg,
Deutschland ("GSF") (BAVARIAN NORDIC and GSF jointly referred to as "LICENSORS") and
	 	 	 
		(3)	Bio Blue Bird AG, Pflugstr. 7, FL-9490 Vaduz, Liechtenstein ("LICENSEE").

 

	WHEREAS 	LICENSEE and LICENSORS entered Into a License Agreement on 6 July 2005 ("License Agreement") whereby LICENSEE was granted a non-exclusive license to, in particular, further develop, make, have made (including services under contract for Licensee or sub-licensee, by Contract Manufacturing Organizations, Contract Research Organisations, Consultants, Logistics Companies or others), obtain marketing approval, sell and offer for sale the Licensed Product or otherwise use the Licensed Patent Rights in the Territory within the Field of this Agreement.
	 	 
	WHEREAS 	LICENSEE and LICENSORS amended the License Agreement on 20 December 2006 ("Amendment") to reflect: (i) the license granted shall be exclusive; (ii) a royalty rate increase; (iii) LICENSEE taking over expenses; and (iv) to make clear that the license will survive as a license granted by one of the LICENSORS if the other LICENSOR rejects performance under the License Agreement due to any actions or declarations of insolvency.
	 	 
	WHEREAS	LICENSEE and LICENSORS now desire to further amend the License Agreement in order to include the right to import, reflect Ownership and Notification of Improvements, clarify which provisions survive expiration or termination of the License Agreement, to provide rights to the LICENSEE to the Clinical Data after the expiration of the Licensed Patent Rights and to change the Notice address and recipients of LICENSEE.

 

It is agreed:

 

Clause 3.1 of the License Agreement shall be deleted and replaced
with the following:

 

	3.1	License to LICENSEE. Subject to the terms of this Agreement, LICENSORS hereby grant to LICENSEE the exclusive irrevocable
(except as provided for in clause 9.2) royalty-bearing, license, with the right to sublicense in accordance with Clause 3.2, under
the Licensed Patent Rights to further develop, make, have made (including services under contract for Licensee or sub-licensee,
by Contract Manufacturing Organizations, Contract Research Organizations, Consultants, Logistics
Companies or others), obtain marketing approval, sell, import and offer for sale the Licensed Product or otherwise use the Licensed
Patent Rights in the Territory within the Field of this Agreement.

 

 

 

    	 	2	 

     

    

 

Clause 4.1 of the License Agreement shall be deleted and replaced
with the following:

 

	4.1	BAVARIAN NORDIC hereby grants
LICENSEE and any sub-licensee, the exclusive right to use the Clinical Data (Annex 1) that may be deemed necessary or appropriate
in order for LICENSEE or any sub-licensee to develop, make, have made (including services under contract for LICENSEE or sub-licensee,
by Contract Manufacturing Organizations, Contract Research Organizations, Consultants, Logistics Companies or others), obtain
marketing approval, sell, import and offer for sale the Licensed Products or otherwise use the Clinical Data pursuant to Clause
3.

 

Clause 6.3 of the License Agreement shall be deleted and replaced
with the following:

 

	6.3	Patent Prosecution. LICENSORS shall have the sole and exclusive right, except as otherwise provided below, to file, prosecute
and maintain any patents with claims covering inventions in the Licensed Patent Rights. LICENSORS shall use good faith, diligent
efforts to file, prosecute, and maintain such patents, including Supplementary Protection Certificates ("SPC") and Patent
Term Extensions ("PTE") and the like, and shall consider the best interest of both LICENSEE and LICENSORS in so doing;
provided, however, that LICENSOR shall defer to the LICENSEES request as to which patent(s), if any, should be the subject of an
application for and/or selection of such SPC, PTE or the like. However, any such request by Licensee to obtain any such Patent
Term Extension shall be procured by a mutually agreed external counsel. LICENSEE is solely responsible for providing all information
required to obtain any Patent Term Extension, and within the relevant period for such filing, to said external counsel including,
but not limited to, the identity of the product subject to regulatory review, the identity of the patent for which extension is
being sought and the identity of each claim, all information needed to enable the eligibility of a patent for extension, the description
of the activities undertaken by the applicant, or the LICENSEE as the case may be, during the applicable regulatory review period,
and any other information required to obtain said Patent Term Extension. LICENSORS shall provide the external counsel all necessary
assistance in terms of documentation and declarations that pertain to said patents needed to obtain Patent Term Extension.

As of the first day of January 2007 LICENSEE will bear LICENSORS' external attorneys' costs and official fees
necessary for filing, prosecuting and maintaining any patent claims covering inventions in the Licensed Patent Rights. LICENSORS'
internal costs will be borne by themselves. At the end of each calendar quarter LICENSORS shall send LICENSEE a detailed specification
of external costs and fees incurred in that quarter, if any. Upon receipt of such specification LICENSEE shall pay the external
costs and fees within one month to the invoicing LICENSOR. Upon request from the LICENSEE, the invoicing LICENSOR shall provide
invoices or other documents evidencing the external costs and fees. Notwithstanding the
foregoing, the cost incurred by an external counsel retained
to procure a Patent Term Extension shall be invoiced to, and paid for directly, by LICENSEE.

 

 

 

    	 	3	 

     

    

 

 

	 	If LICENSORS decline to file or prosecute a patent or maintain a
patent within the Licensed Patent Rights, LICENSORS shall timely, at least three months before any relevant deadline, notify LICENSEE
and LICENSEE may thereafter file and prosecute at its expense a patent or application or maintain a patent claiming such invention.
LICENSORS shall in such case provide to LICENSEE all necessary assistance, in particular assignment declarations and copies of
all relevant patent office correspondence and copies of the relevant patent application and all patent documents. As a result of
its maintenance of such patents or filing and or prosecution of such patent applications (or paying any fees according to this
Clause), LICENSEE shall obtain all rights in these patents (including SPCs and PTEs and the like) and patent applications for that
jurisdiction and cease to be obliged to further pay royalties here based on said patents (including SPCs, PTEs and the like) or
patent applications prosecuted or maintained at its own expense.

 

Clause 9.3.1 of the License Agreement shall be deleted and replaced
with the following:

 

	9.3.1	In the event of termination or expiry of this Agreement, the following provisions (Clauses) of this Agreement shall survive in their entirety (2.2, 6.7, 8, 9.3, 13.1, 13.2, 13.3, 14.1, 14.4, 14.7).

 

The following Clause 9.3.3 shall be added to the License Agreement
as follows:

 

	9.3.3	Upon expiration, but not earlier termination, pursuant to Section 9.1, Licensee will have a non-exclusive, irrevocable, perpetual, fully-paid license, with the right to sublicense, to use the Clinical Data (Annex 1) as set forth in Clause 4.1.

 

The Notices "To LICENSEE", including
"With copies to" set forth in Clause 14.7 of the License Agreement, are hereby deleted and restated as follows:

 

	To LICENSEE:	Bio Bluebird AG
	 	Pflugstrasse 7
	 	FL-9490
	 	Vaduz, Liechtenstein
	 	Attn: Dr. Kenneth L. Waggoner

 

 

  

	With copies to:	PharmaCyte Biotech, Inc.
	 	23046 Avenida de la Carlota
	 	Suite 600
	 	Laguna Hills, California 92653 USA
	 	Attn: Dr. Kenneth L. Waggoner

 

 

    	 	4	 

     

    

 

	If to GSF:	
        Helmholtz Zentrum Munchen

        Deutsches Forschungszentrum fur Gesundheit und

        Umwelt (GmbH)

	(now HMGU)	Legal Affairs
	 	Ingolstadter Landstrafle 1
	 	85764 Neuherberg
	 	Attn: Head of Legal Affairs and Head of Innovation Management (2016744)

 

 

Except as amended and set forth above, the
License Agreement shall continue in full force and effect.

 

 

 

    	 	5EX-4.1

 Exhibit 4.1 

REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of October 4, 2016 by and among
EOG Resources, Inc., a Delaware corporation (“Parent”), and each Person set forth on the signature pages hereto as a “Company Stockholder” (collectively, the “Company Stockholders” and each,
a “Company Stockholder”), as holders of outstanding equity securities in the Company. 
 RECITALS 

WHEREAS, this Agreement is made in connection with (1) the closing of the transactions contemplated by the Agreement and Plan of Merger,
as amended (the “Merger Agreement”), dated as of the date hereof, by and among Parent, ERI Holdings I, Inc., a New Mexico corporation and wholly owned subsidiary of Parent (“Merger Sub”), and Yates
Petroleum Corporation, a New Mexico corporation (the “Company”), and (2) the issuance of the Subject Common Stock on the Closing Date pursuant to the Merger Agreement; and 

WHEREAS, Parent has agreed to provide the registration and other rights set forth in this Agreement for the benefit of the Company
Stockholders who will receive Subject Common Stock on the Closing Date as the Merger Consideration. 
 NOW, THEREFORE, in consideration of
the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party hereto, the parties hereby agree as follows: 

ARTICLE I 

REGISTRATION RIGHTS 

Section 1.01 Shelf Registration. 

(a) Shelf Registration. Parent shall (i) prepare and file a registration statement under the Securities Act to
permit the public resale of the Registrable Securities from time to time, including as permitted by Rule 415 under the Securities Act (or any similar provision then in force), with respect to all of the Registrable Securities (the
“Shelf Registration Statement”) and (ii) cause such Shelf Registration Statement to become effective as soon as reasonably practicable thereafter but in no event later than 60 days after the Closing (the
“Effectiveness Deadline”). The Shelf Registration Statement filed pursuant to this Section 1.01(a) shall be on Form S-3 of the SEC if Parent is eligible to use Form S-3 or Form S-1 of the SEC if
Parent is not eligible to use Form S-3. Subject to Section 1.01(b), Parent will cause the Shelf Registration Statement filed pursuant to this Section 1.01(a) to be continuously effective under the Securities Act from and
after the date it is first declared or becomes effective until all Registrable Securities covered by the Shelf Registration Statement have been distributed in the manner set forth and as contemplated in the Shelf Registration Statement or there are
no longer any Registrable Securities outstanding (the “Effectiveness Period”). The Shelf Registration Statement when declared effective (including the documents incorporated therein by reference) shall comply as to form with
all applicable requirements of the Securities Act and the Exchange Act and shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading. As soon as practicable following the beginning of the Effectiveness Period, but in any event within three Business Days of such date, Parent will notify the Selling Holders of the effectiveness of such Shelf Registration Statement. 

 (b) Delay Rights. Notwithstanding anything to the contrary contained
herein, Parent may, upon written notice to any Selling Holder whose Registrable Securities are included in the Shelf Registration Statement, suspend such Selling Holder’s use of any prospectus which is a part of the Shelf Registration
Statement (in which event the Selling Holder shall discontinue sales of the Registrable Securities pursuant to the Shelf Registration Statement but such Selling Holder may settle any contracted sales of Registrable Securities) if Parent
(i) is pursuing an acquisition, merger, reorganization, disposition or other similar transaction that Parent reasonably believes would be required by applicable law to be disclosed in the Shelf Registration Statement and the Parent Board
determines in good faith that its ability to pursue or consummate such a transaction would be materially and adversely affected by any required disclosure of such transaction in the Shelf Registration Statement or (ii) has experienced some
other material non-public event the disclosure of which at such time, in the good faith judgment of the Parent Board would materially and adversely affect Parent; provided, however, in no event shall such Selling Holders be
suspended under clauses (i) or (ii) of this Section 1.01(b) from selling Registrable Securities pursuant to the Shelf Registration Statement for a period that exceeds 30 consecutive days or 45 days in the
aggregate. Upon disclosure of such information or the termination of the condition described above, Parent shall provide prompt notice to the Selling Holders whose Registrable Securities are included in the Shelf Registration Statement, and shall
promptly terminate any suspension of sales it has put into effect and shall take such other actions to permit registered sales of Registrable Securities as contemplated in this Agreement. 

Section 1.02 Registration Procedures. 

(a) In connection with its obligations under this Article I, Parent will, as expeditiously as possible: 

(i) prepare and file with the SEC such amendments and supplements to the Shelf Registration Statement and the prospectus used
in connection therewith as may be necessary to cause the Shelf Registration Statement to be effective and to keep the Shelf Registration Statement effective for the Effectiveness Period and as may be necessary to comply with the provisions of the
Securities Act with respect to the disposition of all securities covered by the Shelf Registration Statement; 
 (ii) furnish
to each Selling Holder and each Selling Holder’s representatives and counsel designated in writing by such Selling Holder to Parent (A) as far in advance as reasonably practicable before filing the Shelf Registration Statement or any
amendment or supplement thereto a copy of a reasonably complete draft of such Shelf Registration Statement or any amendment or supplement thereto, and provide each such Selling Holder the opportunity to object to any information pertaining to such
Selling Holder and its plan of distribution that is contained therein and make the corrections reasonably requested by such Selling Holder with respect to such information prior to filing the Shelf Registration Statement or any amendment or
supplement thereto, and (B) a copy of the filed Shelf Registration Statement or any amendment or supplement thereto; 

(iii) promptly notify each Selling Holder, at any time when (A) a prospectus relating thereto is required to be delivered
under the Securities Act, of the filing of the Shelf Registration Statement or any amendment or supplement thereto, and, when the same has become effective, (B) the receipt of any written comments from the SEC with respect to any filings
referred to in clause (A) and any written request by the SEC for amendments or supplements to a Shelf Registration Statement, or (C) copies of any and 

  
 2 

 
all transmittal letters or other correspondence filed via EDGAR with the SEC or any other Governmental Authority relating to a Shelf Registration Statement (it being understood that each Selling
Holder receiving any materials from Parent contemplated herein shall (and shall cause its representatives and counsel to) keep such materials confidential); 

(iv) immediately notify each Selling Holder, each Selling Holder’s representatives and counsel, and each underwriter of
Registrable Securities, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of (A) the happening of any event as a result of which the prospectus or prospectus supplement contained in the Shelf
Registration Statement or any other registration statement contemplated by this Agreement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the
statements therein not misleading, in the light of the circumstances then existing; (B) the issuance or threat of issuance by the SEC of any stop order suspending the effectiveness of the Shelf Registration Statement or any other registration
statement contemplated by this Agreement, or the initiation of any Proceedings for that purpose; or (C) the receipt by Parent of any notification with respect to the suspension of the qualification of any Registrable Securities for sale under
the applicable securities or “Blue Sky” laws of any jurisdiction. Following the provision of such notice, Parent agrees to as promptly as practicable amend or supplement the prospectus or prospectus supplement or take other appropriate
action so that the prospectus or prospectus supplement does not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, in the light of
the circumstances then existing, and to take such other action as is necessary to remove a stop order, suspension, threat thereof or Proceedings related thereto; 

(b) Each Selling Holder, upon receipt of notice from Parent of the happening of any event of the kind described in
Section 1.02(a)(iv), shall forthwith discontinue disposition of the Registrable Securities until it is advised in writing by Parent that the use of the prospectus may be resumed. Parent shall extend the period of time during which Parent
is required to maintain the Shelf Registration Statement effective pursuant to this Agreement by the number of days during the period from and including the date of the giving of notice from Parent pursuant to Section 1.02(a)(iv) to and
including the date the Selling Holder is advised in writing by Parent that the use of the prospectus may be resumed. 
 Section 1.03
Registrable Securities. Any Registrable Security will cease to be a Registrable Security when (a) a registration statement covering such Registrable Security is effective and such Registrable Security has been sold or disposed of
pursuant to such effective registration statement; (b) such Registrable Security has been disposed of pursuant to any section of Rule 144; or (c) such security becomes eligible for sale pursuant to Rule 144 without volume or
manner-of-sale restrictions and without the requirement for Parent to be in compliance with the current public information requirement under Rule 144(c)(1). 

Section 1.04 Lack of Required Information. Parent shall have no obligation to include in the Shelf Registration Statement any
shares of Subject Common Stock of a Holder who has failed to timely furnish such information which, in the opinion of counsel to Parent, is reasonably required to be furnished or confirmed in order for the registration statement or prospectus
supplement thereto, as applicable, to comply with the Securities Act. 

  
 3 

 Section 1.05 Disclosure of Information. Any Company Stockholder desiring to have its
Registrable Securities included in the Shelf Registration Statement shall provide to Parent all information required to be disclosed therein. Except to the extent such information is disclosed in the Shelf Registration Statement, Parent shall (and
shall cause its agents and representatives to) hold all such information in confidence and not make any disclosure thereof unless (a) the disclosure of such information is necessary to comply with federal or state securities laws, (b) the
disclosure of such information is necessary to avoid or correct an untrue statement of a material fact required to be stated in the Shelf Registration Statement, (c) the release of such information is ordered pursuant to a subpoena or other
final, non-appealable order from a Governmental Authority of competent jurisdiction, or (d) such information has been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement. Parent
agrees that it shall, upon learning that disclosure of any such information (other than that disclosed in the Shelf Registration Statement) is sought in or by a Governmental Authority of competent jurisdiction or through other means, give prompt
written notice to such Company Stockholder and allow such Company Stockholder to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information. 

Section 1.06 Expenses. Parent will pay all expenses incident to Parent’s performance under or compliance with this Agreement
to effect the registration of Registrable Securities on the Shelf Registration Statement, including, without limitation, all registration, filing, securities exchange listing fees, all customary registration, filing, qualification and other fees and
expenses of complying with securities or “Blue Sky” laws, fees of transfer agents and registrars, all word processing, duplicating and printing expenses, and the fees and disbursements of counsel and independent public accountants and
independent reserve engineers for Parent. Notwithstanding the foregoing, “registration expenses” described in this Section 1.06 shall exclude all selling commissions and similar fees and fees of counsel incurred by any Company
Stockholder in connection with the sale of any Registrable Securities. 
 Section 1.07 Opt-Out. At least 10 Business Days before
the initial filing of the Shelf Registration Statement, Parent shall deliver notice to each Company Stockholder (the “Filing Notice”) stating the date (the “Intended Filing Date”) upon which Parent
intends to file the Shelf Registration Statement with the SEC. Notwithstanding whether such Company Stockholder has previously delivered to Parent the information contemplated by Sections 1.04 and 1.05, if a Company Stockholder
delivers a notice to Parent at least three Business Days before the Intended Filing Date stating that such Company Stockholder desires to be excluded from the Shelf Registration Statement, then Parent shall not include the Registrable Securities of
such Company Stockholder, or any information with respect to such Company Stockholder in the Shelf Registration Statement. Parent may for any reason file the Shelf Registration Statement on or after the Intended Filing Date but in no event shall
Parent file the Shelf Registration Statement before the Intended Filing Date. 
 Section 1.08 Indemnification. 

(a) By Parent. In the event of a registration of any Registrable Securities under the Securities Act pursuant to
this Agreement, Parent will indemnify and hold harmless each Selling Holder thereunder, its Affiliates that own Registrable Securities and their respective directors, officers, managers, members, partners, stockholders, Affiliates or any other
Person acting on behalf of such holder of Registrable Securities and each Person, if any, who controls such Selling Holder within the meaning of the Securities Act and the Exchange Act and its directors, officers, managers, members, partners,
stockholders, Affiliates or any other Person acting on behalf of such holder of Registrable Securities (collectively, the “Selling Holder Indemnified Persons”), against any losses, claims, damages, expenses or liabilities
(including reasonable attorneys’, accountants’ and experts’ fees and expenses) (collectively, “Losses”), joint or several, to which such Selling Holder or controlling Person may become subject under the
Securities Act, the 

  
 4 

 
Exchange Act or otherwise, insofar as such Losses (or Proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained in the Shelf Registration Statement or any other registration statement contemplated by this Agreement, any prospectus contained therein, or any amendment or supplement thereof, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in light of the circumstances under which they were made) not misleading,
in connection with the registration statement in respect of any registration of Parent’s securities, and will reimburse each such Selling Holder Indemnified Person for any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such Loss or Proceedings; provided, however, that Parent will not be liable in any such case if and to the extent that any such Loss arises out of or is based upon an untrue statement or alleged untrue
statement or omission or alleged omission so made in conformity with information furnished by such Selling Holder Indemnified Person in writing specifically for use in the Shelf Registration Statement or such other registration statement or any
prospectus (including, if applicable, any preliminary or free writing prospectus) contained therein or any amendment or supplement thereof. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of
such Selling Holder or any such director, officer or controlling Person, and shall survive the transfer of such securities by such Selling Holder. 

(b) By Each Selling Holder. Each Selling Holder agrees severally and not jointly to indemnify and hold harmless
Parent, its directors and officers, and each Person, if any, who controls Parent within the meaning of the Securities Act or of the Exchange Act against any Losses to the same extent as the foregoing indemnity from Parent to the Selling Holders, but
only with respect to information regarding such Selling Holder furnished in writing by or on behalf of such Selling Holder expressly for inclusion in the Shelf Registration Statement or any prospectus (including, if applicable, any preliminary or
free writing prospectus) contained therein or any amendment or supplement thereof relating to the Registrable Securities; provided, however, that the liability of each Selling Holder shall not be greater in amount than the dollar
amount of the proceeds received by such Selling Holder from the sale of the Registrable Securities giving rise to such indemnification. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of
Parent or any such director, officer or controlling Person, and shall survive the transfer of such securities by such Selling Holder. 

(c) Notice. Promptly after receipt by an indemnified party hereunder of notice of the commencement of any action,
such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party in writing thereof, but such indemnified party’s failure to so notify the indemnifying party shall
not relieve the indemnifying party from any liability which it may have to any indemnified party other than under this Section 1.07. The indemnifying party shall be entitled to participate in and, to the extent it shall wish, to assume
and undertake the defense thereof with counsel reasonably satisfactory to such indemnified party and, after notice from the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying
party shall not be liable to such indemnified party under this Section 1.07 for any legal expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation and of
liaison with counsel so selected; provided, however, that, (i) if the indemnifying party has failed to assume the defense and employ counsel reasonably acceptable to the indemnified party or (ii) if the defendants in any such
action include both the indemnified party and the indemnifying party and counsel to the indemnified party shall have concluded that there may be reasonable defenses available to the indemnified 

  
 5 

 
party that are different from or additional to those available to the indemnifying party, or if the interests of the indemnified party reasonably may be deemed to conflict with the interests of
the indemnifying party, then the indemnified party shall have the right to select a separate counsel and to assume such legal defense and otherwise to participate in the defense of such action, with the reasonable expenses and fees of one such
separate counsel (firm) and other reasonable expenses related to such participation to be reimbursed by the indemnifying party as incurred. Notwithstanding any other provision of this Agreement, no indemnified party shall settle any action
brought against it with respect to which it is entitled to indemnification hereunder without the consent of the indemnifying party, unless the settlement thereof imposes no liability or obligation on, and includes a complete and unconditional
release from all liability of, the indemnifying party. 
 (d) Contribution. If the indemnification provided for
in this Section 1.07 is held by a Governmental Authority of competent jurisdiction to be unavailable to Parent or any Selling Holder Indemnified Person or is insufficient to hold it harmless in respect of any Losses, then each such
indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such Losses as between Parent, on the one hand, and such Selling Holder Indemnified Person,
on the other hand, in such proportion as is appropriate to reflect the relative fault of Parent, on the one hand, and of such Selling Holder Indemnified Person, on the other, in connection with the statements or omissions which resulted in such
Losses, as well as any other relevant equitable considerations; provided, however, that in no event shall such Selling Holder Indemnified Person be required to contribute an aggregate amount in excess of the dollar amount of proceeds
received by such Selling Holder Indemnified Person from the sale of Registrable Securities giving rise to such indemnification. The relative fault of Parent, on the one hand, and each Selling Holder Indemnified Person, on the other hand, shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact has been made by, or relates to, information supplied by such party, and
the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just and equitable if contributions pursuant to this paragraph were
to be determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the first sentence of this paragraph. The amount paid by an indemnifying party as a result of the
Losses referred to in the first sentence of this paragraph shall be deemed to include any legal and other expenses reasonably incurred by such indemnified party in connection with investigating or defending any Loss which is the subject of this
paragraph. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who is not guilty of such fraudulent misrepresentation. 

(e) Other Indemnification. The provisions of this Section 1.07 shall be in addition to any other
rights to indemnification or contribution which an indemnified party may have pursuant to law, equity, contract or otherwise. 

Section 1.09 Rule 144 Reporting. With a view to making available the benefits of certain rules and regulations of the SEC
that may permit the sale of the Registrable Securities to the public without registration, Parent agrees to use its reasonable best efforts to: 

(a) make and keep public information regarding Parent available, as those terms are understood and defined in Rule 144, at
all times from and after the Closing Date; 

  
 6 

 (b) file with the SEC in a timely manner all reports and other documents required
of Parent under the Securities Act and the Exchange Act at all times from and after the Closing Date; and 
 (c) take such
further action as any Holder may reasonably request, all to the extent required from time to time to enable the Holders to sell Registrable Securities without registration under the Securities Act within the limitations of the exemption provided by
Rule 144. 
 Section 1.10 Regulation M. Parent will not take any direct or indirect action prohibited by Regulation M under
the Exchange Act. 
 Section 1.11 Cooperation. Parent shall cooperate with the holders of the Registrable Securities to
facilitate the timely preparation and delivery of certificates representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free of any restrictive legends and representing such number of shares of Common
Stock as the holders of the Registrable Securities may reasonably request in connection with any sales of Registrable Securities pursuant to such Registration Statement or Rule 144; provided, that Parent may satisfy its obligations hereunder
without issuing physical stock certificates. 
 Section 1.12 No Transfer or Assignment. Except with respect to a transferee
pursuant to a transfer permitted under Section 1.14(c), the rights to cause Parent to include Registrable Securities in a Shelf Registration Statement may not be transferred or assigned by any Company Stockholder. 

Section 1.13 Requested Information. Any Holder or Holders of Registrable Securities included in any registration statement shall
promptly furnish to Parent such information regarding such Holder or Holders and the distribution or transfer proposed by such Holder or Holders as Parent may reasonably request and as shall be required in connection with any registration,
qualification or compliance referred to herein. 
 Section 1.14 Graduated Lock-up. 

(a) 100% Lock-up Period (0-60 Days). Subject to Section 1.14(c), notwithstanding the filing and
effectiveness of the Shelf Registration Statement, each Holder hereby agrees that it will not (and will cause its Affiliates not to), without the prior written consent of Parent, during the period commencing on the Closing Date and ending
immediately before the commencement of trading on the 61st calendar day immediately following the Closing Date (or, if such calendar day is not a trading day, then the immediately succeeding trading day) (i) lend; offer; pledge; sell; contract
to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Subject Common Stock or any
securities convertible into or exercisable or exchangeable (directly or indirectly) for Subject Common Stock (whether such shares or any such securities are then owned by the Holder or are thereafter acquired) or (ii) enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by
delivery of Subject Common Stock or other securities, in cash, or otherwise. 
 (b) 50% Lock-up Period (61-120
Days). Subject to Section 1.14(c), each Holder hereby agrees that it will not (and will cause its Affiliates not to), without the prior written consent of Parent, during the period commencing at the commencement of trading on the
61st calendar day immediately following the Closing Date (or, if such calendar day is not a trading 

  
 7 

 
day, then the immediately succeeding trading day) and ending immediately before the commencement of trading on the 121st calendar day immediately following the Closing Date (or, if such calendar
day is not a trading day, then the immediately succeeding trading day), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to
purchase; or otherwise transfer or dispose of, directly or indirectly, more than 50% of the shares of Subject Common Stock received by such Holder in the Merger or (ii) enter into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Subject Common Stock or other securities,
in cash, or otherwise. 
 (c) Nothing in this Section 1.14 shall prohibit or limit the ability of any Holder to
effect any transfer of shares of Subject Common Stock as a bona fide gift or gifts or any other similar transfer that does not involve a sale or other disposition for value so long as the transferee agrees in writing to be bound by all of the terms
of this Agreement. 
 Section 1.15 Investment Intent. Each Company Stockholder represents to Parent that it has acquired its
Merger Consideration for its own account and not with the intent to make a distribution within the meaning of the Securities Act or a distribution thereof in violation of any other applicable securities laws. Each Company Stockholder will hold its
Merger Consideration for its own account for investment and not with a view to, or for sale or other disposition in connection with, any distribution of all or any part thereof within the meaning of the Securities Act, except in compliance with
applicable federal and state securities laws. 
 ARTICLE II 

MISCELLANEOUS 

Section 2.01 Definitions. Capitalized terms used herein without definition shall have the meanings given to them in the Merger
Agreement, except that the terms set forth below are used herein as so defined: 
 “Common Stock” means shares of
Parent’s common stock, par value $0.01 per share. 
 “Holder” means a holder of any Registrable Securities.

 “Registrable Security” means a share of Subject Common Stock until such time as such security ceases to be a
Registrable Security pursuant to Section 1.03 hereof. 
 “Rule 144” means Rule 144 under the Securities
Act or any successor rule thereto. 
 “SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 “Selling Holder” means a Holder who is selling Registrable Securities pursuant to a registration statement. 

“Subject Common Stock” means Common Stock issued to the Company Stockholders pursuant to the Merger Agreement. 

  
 8 

 Section 2.02 Communications. All notices and other communications provided for
hereunder shall be in writing and shall be given by hand delivery, registered or certified mail, return receipt requested, regular mail, facsimile or air courier guaranteeing overnight delivery to the following addresses: 

if to Parent to: 
 EOG Resources,
Inc. 
 1111 Bagby, Sky Lobby 2 

Houston, Texas 77002 
 Attention:
Lloyd W. Helms, Jr., Executive Vice President, Exploration and Production 
 Fax: (713) 651-6987 

Email: Billy_Helms@eogresources.com 

and 
 EOG Resources, Inc. 

1111 Bagby, Sky Lobby 2 
 Houston,
Texas 77002 
 Attention: Michael P. Donaldson, Exec. VP and General Counsel 

Fax: (713) 651-6987 
 Email:
Michael_Donaldson@eogresources.com 
 with a copy (which shall not constitute notice) to: 

Akin Gump Strauss Hauer & Feld, LLP 

1111 Louisiana Street, 44th Floor 

Houston, Texas 77002 
 Attention:
John Goodgame, Andrew B. Lehman 
 Fax: (713) 236-0822 

Email: jgoodgame@akingump.com, alehman@akingump.com 

if to any Company Stockholder, to the notice address set forth on Schedule 1 attached hereto. 

All notices and communications shall be deemed to have been duly given: (i) at the time delivered by hand, if personally delivered; (ii) upon actual
receipt if sent by registered or certified mail, return receipt requested, or regular mail, if mailed; (iii) upon actual receipt if received during recipient’s normal business hours, or at the beginning of the recipient’s next
Business Day if not received during recipient’s normal business hours, if sent by facsimile and confirmed by appropriate answer-back; and (iv) upon actual receipt when delivered to an air courier guaranteeing overnight delivery. 

Section 2.03 Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the permitted successors and
assigns of each of the parties. 
 Section 2.04 Recapitalization, Exchanges, etc. Affecting the Common Stock. The provisions of
this Agreement shall apply to the full extent set forth herein with respect to any and all common stock of Parent or any successor or assign of Parent (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of,
in exchange for or in substitution of, the Registrable Securities, and shall be appropriately adjusted for combinations, recapitalizations and the like occurring after the date of this Agreement. 

  
 9 

 Section 2.05 Specific Performance. Damages in the event of breach of this Agreement
by a party hereto may be difficult, if not impossible, to ascertain, and it is therefore agreed that each such Person, in addition to and without limiting any other remedy or right it may have, will have the right to an injunction or other equitable
relief in any court of competent jurisdiction, enjoining any such breach, and enforcing specifically the terms and provisions hereof, and each of the parties hereto hereby waives any and all defenses it may have on the ground of lack of jurisdiction
or competence of the court to grant such an injunction or other equitable relief. The existence of this right will not preclude any such Person from pursuing any other rights and remedies at law or in equity which such Person may have. 

Section 2.06 Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in
separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original and all of which counterparts, taken together, shall constitute but one and the same Agreement. 

Section 2.07 Interpretation. When a reference is made in this Agreement to an Article, a Section, Exhibit or Schedule, such
reference shall be to an Article of, a Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The words
“hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. All terms defined in this
Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant hereto unless otherwise defined therein. The definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such
agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes and
references to all attachments thereto and instruments incorporated therein. References to a Person are also to its permitted successors and permitted assigns. Unless specifically provided for herein, the term “or” shall not be deemed to be
exclusive. The word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”. The words “will” and “will not” are
expressions of command and not merely expressions of future intent or expectation. When used in this Agreement, the word “either” shall be deemed to mean “one or the other”, not “both”. All references herein to
“dollars” or “$” are to the lawful currency of the United States. 
 Section 2.08 Governing Law. This
Agreement is governed by and construed and enforced in accordance with the Laws of the State of Delaware, without giving effect to any conflicts of law principles that would result in the application of any Law other than the Law of the State of
Delaware. 
 Section 2.09 WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH PARTY
HEREBY IRREVOCABLY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE, CLAIM, DEMAND, ACTION OR CAUSE OF ACTION ARISING IN WHOLE OR IN PART
UNDER, RELATED TO, BASED ON, OR IN CONNECTION WITH, THIS AGREEMENT OR THE SUBJECT MATTER HEREOF, WHETHER NOW EXISTING OR HEREAFTER ARISING 

  
 10 

 
AND WHETHER SOUNDING IN TORT OR CONTRACT OR OTHERWISE. ANY PARTY MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 2.09 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH
SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 
 Section 2.10 Severability of Provisions. Any provision of this
Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof or affecting or impairing
the validity or enforceability of such provision in any other jurisdiction. 
 Section 2.11 Entire Agreement. This Agreement is
intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. There are no
restrictions, promises, warranties or undertakings, other than those set forth or referred to herein with respect to the rights granted by Parent set forth herein. This Agreement and the Merger Agreement supersede all prior agreements and
understandings between the parties with respect to such subject matter. 
 Section 2.12 Amendment. This Agreement may be amended
only by means of a written amendment signed by Parent and the Holders of a majority of the then outstanding Registrable Securities; provided, however, that no such amendment shall materially and adversely affect the rights of any
Holder hereunder without the consent of such Holder. 
 Section 2.13 No Presumption. In the event any claim is made by a party
relating to any conflict, omission, or ambiguity in this Agreement, no presumption or burden of proof or persuasion shall be implied by virtue of the fact that this Agreement was prepared by or at the request of a particular party or its counsel.

 Section 2.14 Further Assurances. Parent and each of the Holders shall cooperate with each other and shall take such further
action and shall execute and deliver such further documents as may be reasonably requested by any other party in order to carry out the provisions and purposes of this Agreement. 

[Signature page follows.] 

  
 11 

 IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date
and year first written above. 
  

			
	PARENT:
	
	EOG RESOURCES, INC.
		
	By:	 	 /s/ Lloyd W. Helms, Jr.

	Name:	 	Lloyd W. Helms, Jr.
	Title:	 	Executive Vice President, Exploration and Production

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	ANDREW P. YATES 2012 IRREVOCABLE TRUST
	
	By: Century Bank, Trustee
		
	By:	 	 /s/ Bernadette M. Rodriguez

	Name:	 	Bernadette M. Rodriguez
	Title:	 	Vice-President

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	BOBBY AND SHARI SMITH 2012 DELAWARE TRUST
	
	By: J.P. Morgan Trust Company Of Delaware, Trustee
		
	By:	 	 /s/ Andrea S. Davis

	Name:	 	Andrea S. Davis
	Title:	 	Vice President

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	BOW BROOK LLLP
		
	By:	 	 /s/ Peyton William Yates Davis

	Name:	 	Peyton William Yates Davis
	Title:	 	General Partner

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Brenda R. Yates

	Brenda R. Yates

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Brenda Yates

	Brenda Yates

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	COURTNEY S. YATES 2012 IRREVOCABLE TRUST
	
	By: Century Bank, Trustee
		
	By:	 	 /s/ Bernadette M. Rodriguez

	Name:	 	Bernadette M. Rodriguez
	Title:	 	Vice-President

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Cynthia Ann Yates Price

	Cynthia Ann Yates Price

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	DADS LIFEWORK LP
	
	By: PY Cabin, LLC, its Managing Partner
		
	By:	 	 /s/ Peyton Yates

	Name:	 	Peyton Yates
	Title:	 	Managing Member

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Darin Eugene Yates

	Darin Eugene Yates

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Douglas E. Brooks

	Douglas E. Brooks

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	FOGHORN’S BABY EHY FOR ANDREW PORTER YATES
		
	By:	 	 /s/ Richard Martin Yates

	Name:	 	Richard Martin Yates
	Title:	 	Trustee

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	FOGHORN’S BABY EHY FOR COURTNEY ST. CLAIR YATES
		
	By:	 	 /s/ Richard Martin Yates

	Name:	 	Richard Martin Yates
	Title:	 	Trustee

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	FOGHORN’S BABY EHY FOR KELSY MEGAN YATES
		
	By:	 	 /s/ Richard Martin Yates

	Name:	 	Richard Martin Yates
	Title:	 	Trustee

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Frank Yates, Jr.

	Frank Yates, Jr.

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	IRREVOCABLE TREY YATES TRUST
		
	By:	 	 /s/ Dan Lewis

	Name:	 	Dan Lewis
	Title:	 	Trustee

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Jeffrey Martin Price

	Jeffrey Martin Price

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	JO ANN YATES 2012 DELAWARE TRUST
	
	By: J.P. Morgan Trust Company Of Delaware, Trustee
		
	By:	 	 /s/ Andrea S. Davis

	Name:	 	Andrea S. Davis
	Title:	 	Vice President

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	JO ANN YATES 2013 DELAWARE TRUST
	
	By: J.P. Morgan Trust Company Of Delaware, Trustee
		
	By:	 	 /s/ Andrea S. Davis

	Name:	 	Andrea S. Davis
	Title:	 	Vice President

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ John A. Yates, III

	John A. Yates, III

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	JOHN A. YATES, SR. TRUST ESTABLISHED UNDER THE JOHN A. YATES, SR. AND CHARLOTTE G. YATES REVOCABLE TRUST
		
	By:	 	 /s/ John A. Yates, Sr.

	Name:	 	John A. Yates, Sr.
	Title:	 	Trustee

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	JOHN YATES, JR. AND NANCY YATES REVOCABLE TRUST
		
	By:	 	 /s/ John A. Yates, Jr.

	Name:	 	John A. Yates, Jr.
	Title:	 	Co-Trustee
		
	By:	 	 /s/ Nancy E. Yates

	Name:	 	Nancy E. Yates
	Title:	 	Co-Trustee

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	KELSY M. YATES 2012 IRREVOCABLE TRUST
	
	By: Century Bank, Trustee
		
	By:	 	 /s/ Bernadette M. Rodriguez

	Name:	 	Bernadette M. Rodriguez
	Title:	 	Vice-President

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Nicole S. Price Wesselmann

	Nicole S. Price Wesselmann

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Nicole Sara Price Wesselmann

	Nicole Sara Price Wesselmann

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	PY FOUNDATION
		
	By:	 	 /s/ Peyton Yates

	Name:	 	Peyton Yates
	Title:	 	President

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Richard M. Yates

	Richard M. Yates

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Ryan Ashby Price

	Ryan Ashby Price

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	SACRAMENTO PARTNERS LIMITED PARTNERSHIP
	
	By: Weed Oil & Gas Co., LLP, its general partner
		
	By:	 	 /s/ Peyton Yates

	Name:	 	Peyton Yates
	Title:	 	Manager
		
	By:	 	 /s/ Richard Yates

	Name:	 	Richard Yates
	Title:	 	Manager
		
	By:	 	 /s/ Peyton William Yates Davis

	Name:	 	Peyton William Yates Davis
	Title:	 	Manager

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	SCOTT AND JILL YATES 2012 DELAWARE TRUST
	
	By: J.P. Morgan Trust Company Of Delaware, Trustee
		
	By:	 	 /s/ Andrea S. Davis

	Name:	 	Andrea S. Davis
	Title:	 	Vice President

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Sean Joseph Price

	Sean Joseph Price

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ Shari Ann Yates

	Shari Ann Yates
	

 Signature Page to 

Registration Rights Agreement 

 
	
	COMPANY STOCKHOLDERS:
	
	 /s/ St. Clair Peyton Yates, Jr.

	St. Clair Peyton Yates, Jr.

 Signature Page to 

Registration Rights Agreement 

 
			
	COMPANY STOCKHOLDERS:
	
	TRUST Q, U/W/O PEGGY A YATES, DECEASED
		
	By:	 	 /s/ John A. Yates, Sr.

	Name:	 	John A. Yates, Sr.
	Title:	 	Trustee

 Signature Page to 

Registration Rights Agreement 

 SCHEDULE 1 

TO 

REGISTRATION RIGHTS AGREEMENT 

ADDRESSES FOR NOTICES TO COMPANY STOCKHOLDERS 
  

			
	 COMPANY STOCKHOLDER
	  	 ADDRESS FOR NOTICES

		
	Andrew P. Yates 2012 Irrevocable Trust	  	 Century Trust & Asset Management
 c/o Alan
Snow
 100 S. Federal Place
 Santa Fe, NM 87501

		
	Bobby and Shari Smith 2012 Delaware Trust	  	 JPMorgan Trust Company of DE
 500 Stanton
Christiana Road
 Newark, DE 19713-2107

		
	Bow Brook LLLP	  	 101 South 4th Street
 Artesia, NM
88210

		
	Brenda R. Yates	  	 428 Sandoval
 Suite 200

Santa Fe, NM 87501

		
	Brenda Yates	  	 428 Sandoval
 Suite 200

Santa Fe, NM 87501

		
	Courtney S. Yates 2012 Irrevocable Trust	  	 Century Trust & Asset Management
 c/o Alan
Snow
 100 S. Federal Place
 Santa Fe, NM 87501

		
	Cynthia Ann Yates Price	  	 411 W. Main Street
 Artesia, NM
88210

		
	Dads Lifework LP	  	 101 S. 4th Street
 Suite B

Artesia, NM 88210

		
	Darin Eugene Yates	  	 4007 111th
 Lubbock, TX 79423

		
	Douglas E. Brooks	  	 2602 W. Ritchey Ave.
 Artesia, NM
88210

		
	Foghorn’s Baby EHY for Andrew Porter Yates	  	 428 Sandoval
 Suite 200

Santa Fe, NM 87501

		
	Foghorn’s Baby EHY for Courtney St. Clair Yates	  	 428 Sandoval
 Suite 200

Santa Fe, NM 87501

			
	 COMPANY STOCKHOLDER
	  	 ADDRESS FOR NOTICES

		
	Foghorn’s Baby EHY for Kelsy Megan Yates	  	 428 Sandoval
 Suite 200

Santa Fe, NM 87501

		
	Frank Yates, Jr.	  	 403 W. San Francisco
 Santa Fe, NM
87501

		
	Irrevocable Trey Yates Trust	  	 411 W. Main Street
 Artesia, NM
88210

		
	Jeffrey Martin Price	  	 411 W. Main Street
 Artesia, NM
88210

		
	Jo Ann Yates 2012 Delaware Trust	  	 JPMorgan Trust Company of DE
 500 Stanton
Christiana Road
 Newark, DE 19713-2107

		
	Jo Ann Yates 2013 Delaware Trust	  	 JPMorgan Trust Company of DE
 500 Stanton
Christiana Road
 Newark, DE 19713-2107

		
	John A. Yates, III	  	 411 W. Main Street
 Artesia, NM
88210

		
	John A. Yates, Sr. Trust Established Under the John A. Yates, Sr. and Charlotte G. Yates Revocable Trust	  	 410 W. Main Street
 Artesia, NM
88210

		
	John Yates Jr. and Nancy Yates Revocable Trust	  	 411 W. Main Street
 Artesia, NM
88210

		
	Kelsy M. Yates 2012 Irrevocable Trust	  	 Century Trust & Asset Management
 c/o Alan
Snow
 100 S. Federal Place
 Santa Fe, NM 87501

		
	Nicole S. Price Wesselmann	  	 411 W. Main Street
 Artesia, NM
88210

		
	Nicole Sara Price Wesselmann	  	 411 W. Main Street
 Artesia, NM
88210

		
	PY Foundation	  	 101 S. 4th Street
 Suite B

Artesia, NM 88210

			
	 COMPANY STOCKHOLDER
	  	 ADDRESS FOR NOTICES

		
	Richard M. Yates	  	 428 Sandoval
 Suite 200

Santa Fe, NM 87501

		
	Ryan Ashby Price	  	 411 W. Main Street
 Artesia, NM
88210

		
	Sacramento Partners Limited Partnership	  	 101 S. 4th Street
 Suite B

Artesia, NM 88210

		
	Scott and Jill Yates 2012 Delaware Trust	  	 JPMorgan Trust Company of DE
 500 Stanton
Christiana Road
 Newark, DE 19713-2107

		
	Sean Joseph Price	  	 411 W. Main Street
 Artesia, NM
88210

		
	Shari Ann Yates	  	 Highway 48
 Mile Marker 17

Capitan, NM 88316

		
	St. Clair Peyton Yates, Jr.	  	 101 S. 4th Street
 Suite B

Artesia, NM 88210

		
	Trust Q u/w/o Peggy A. Yates, Deceased	  	 411 W. Main Street
 Artesia, NM
88210

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]